AzTrials
AzTrials

Lumbar SpondylosisLMB-RFANCT06283628

Comparative Effectiveness of Two Different Approaches to Radiofrequency Ablation of Lumbar Medial Branch Nerves

A study testing Radiofrequency ablation of lumbar medial branch nerves. in people with Lumbar Spondylosis, run by Milton S. Hershey Medical Center at 1 site in United States.

Not yet recruiting

Opening soon. The study is approved but enrolment has not started yet. Sites may already take enquiries.

Sites and contacts
Official record
Search all trials

Trial summary

The purpose of this voluntary research study is to determine whether the parasagittal approach to lumbar medial branch (LMB) nerve radio frequency ablation (RFA) will have greater efficacy than the traditional approach to lumbar medial branch nerve radio frequency ablation. Read more about this study

Who is it for?
Ages 18 years and older
Conditions the study is for
Lumbar Spondylosis
What is being tested?
Radiofrequency ablation of lumbar medial branch nerves.
Type of treatment
Surgery or procedure
Could I receive a placebo?
No, everyone receives an active treatment
How many people
25 participants
Where
1 siteUnited States
Study dates
Aug 2027to 30 Dec 2028
Phase
Interventional
Are there results?
Not yet: the study is under way

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 18 years and older
  • All sexes
  • No healthy volunteers
  • Adult, Older adult

Who may be able to join

  • Bilateral equally intense axial low back pain
  • Pain duration of ≥ 6 months
  • Three-day average NRS scores of ≥ 3/10
  • Age greater than 18 years
  • Failure of conservative treatment, including nonsteroidal anti-inflammatory medications and physical therapy
  • Positive response to a series of two bilateral diagnostic lumbar medial branch nerve blocks (≥ 80% pain relief). This is the current standard of care.

Who cannot join

  • Radicular pain below the knee
  • Systemic infection or localized infection at the anticipated introducer entry site
  • Pregnancy
  • Allergy to Lidocaine
  • Bleeding dyscrasias
  • Patients unable to give informed consent
Show all 12Show fewer
  • History of lumbar spine surgery at the affected levels
  • History of previous bilateral lumbar RFA of medial branches within the past six months.
  • Significant comorbid somatization or widespread pain with central sensitization
  • Secondary gain identified due to ongoing legal proceedings or worker's compensation
  • Cognitive impairment
  • Any pre-existing condition at the discretion of the provider that may confound interpretation of results -

Trial locations and contacts

1 site in 1 country. Contact the study team or a site near you to ask about taking part.

Nancy Ruth Jarbadan, BS contact

717-531-6135

njarbadan@pennstatehealth.psu.edu

United States1 site
  • Penn State Hershey College of Medicine

    Hershey, Pennsylvania, 17033

    Nancy Ruth Jarbadan, BS, 717-531-6135, njarbadan@pennstatehealth.psu.edu

Other trials in United States

About this study

The purpose of this voluntary research study is to determine whether the parasagittal approach to lumbar medial branch (LMB) nerve radio frequency ablation (RFA) will have greater efficacy than the traditional approach to lumbar medial branch nerve radio frequency ablation.

Read the detailed description

To determine whether the parasagittal approach to lumbar medial branch (LMB) nerve radiofrequency ablation (RFA) will have greater efficacy than the traditional approach to lumbar medial branch nerve radiofrequency ablation.

This will be accomplished by comparing the results between the newly proposed parasagittal approach and the traditional approach of medial branch RFA done on the same patient (different sites) with bilateral low back pain (LBP).

Traditional approach:

The electrode is introduced at a 15-20 degrees' ipsilateral oblique angle to the sagittal plane toward the junction of the superior articular process (SAP) and transverse process (TP) of the vertebral body to target the traversing medial branch nerve. The reason for the proposed angle is to avoid the mamillo-accessory ligament (MAL) that may be ossified in up to 10% of the normal spine and, in such cases, potentially prevent proper coagulation of the medial branch nerve during the RFA procedure.

Parasagittal (new) approach:

Recently, Tran et al. showed that MAL is located more dorsally than it was thought earlier and, therefore, can't interfere with nerve coagulation during the RFA. Consequently, they proposed abandoning the 20-degree angle used for the traditional approach and placing the radiofrequency cannula parasagittally and more dorsally. It is proposed that, in order to achieve maximum nerve coagulation, the electrode should be placed as parallel to the nerve as possible, and placing it parasagittally helps achieve this goal. The remainder of the procedure does not differ from the traditional method.

Being tested
Radiofrequency ablation of lumbar medial branch nerves.
Medical subject headings
Spondylosis

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Radiofrequency ablation of lumbar medial branch nerves.Procedure or surgery

    Traditional approach:

    The electrode is introduced at a 15-20 degrees' ipsilateral oblique angle to the sagittal plane toward the junction of the superior articular process (SAP) and transverse process (TP) of the vertebral body to target the traversing medial branch nerve.

    Parasagittal (new) approach:

    The RF cannula is placed parasagittally and more dorsally. The remainder of the procedure does not differ from the traditional method.

Study groups in NCT06283628
Study groupRoleWhat they receive
Subjects with traditional approach on the right side and parasagittal approach on the left side.Active comparatorPatients will undergo bilateral RFA; the right side will be done following the traditional approach, and the left side will be done following the parasagittal approach. Traditional approach is done by placing the electrode at a 20 degrees' ipsilateral oblique angle to the sagittal plane toward the junction of the superior articular process and transverse process of the vertebral body to target the traversing medial branch nerve. The reason for the proposed angle is to avoid the mamillo-accessory ligament that may be ossified in up to 10% of the normal spine and potentially prevent proper coagulation of the medial branch nerve during the RFA procedure. Parasagittal (new) approach: is performed by placing the RF cannula parasagittally and more dorsally. To achieve maximum nerve coagulation, the electrode should be placed as parallel to the nerve as possible, and placing it parasagittally helps achieve this goal. The remainder of the procedure does not differ from the traditional method.
Receives: Procedure: Radiofrequency ablation of lumbar medial branch nerves.
Subjects with traditional approach on the left side and parasagittal approach on the right side.Active comparatorPatients will undergo bilateral RFA; the left side will be done following the traditional approach, and the right side will be done following the parasagittal approach. Traditional approach is done by placing the electrode at a 20 degrees' ipsilateral oblique angle to the sagittal plane toward the junction of the superior articular process and transverse process of the vertebral body to target the traversing medial branch nerve. The reason for the proposed angle is to avoid the mamillo-accessory ligament that may be ossified in up to 10% of the normal spine and potentially prevent proper coagulation of the medial branch nerve during the RFA procedure. Parasagittal (new) approach: is performed by placing the RF cannula parasagittally and more dorsally. To achieve maximum nerve coagulation, the electrode should be placed as parallel to the nerve as possible, and placing it parasagittally helps achieve this goal. The remainder of the procedure does not differ from the traditional method.
Receives: Procedure: Radiofrequency ablation of lumbar medial branch nerves.

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. The number of patients whose procedure was successful (gained 50% or more reduction in numeric rating pain (NRS) scores).

    The patients will describe the pain intensity using NRS - 11-point numeric rating scale, with 0 means no pain, and 10 - the worst possible pain intensity.

    Measured: Baseline

  2. The number of patients whose procedure was successful (gained 50% or more reduction in numeric rating pain (NRS) scores).

    The patients will describe the pain intensity using NRS - 11-point numeric rating scale, with 0 means no pain, and 10 - the worst possible pain intensity.

    Measured: 1 month post-procedure.

  3. The number of patients whose procedure was successful (gained 50% or more reduction in numeric rating pain (NRS) scores).

    The patients will describe the pain intensity using NRS - 11-point numeric rating scale, with 0 means no pain, and 10 - the worst possible pain intensity.

    Measured: 6 months post-procedure.

Secondary outcomes (3)
  1. Oswestry Disability index (ODI)

    10 questions assessing the functional impairment by the pain, using a 50 point scale, with 0 meaning no disability, and 50 meaning complete disability.

    Measured: Baseline

  2. Oswestry Disability index (ODI)

    10 questions assessing the functional impairment by the pain, using a 50 point scale, with 0 meaning no disability, and 50 meaning complete disability.

    Measured: 1 month post-procedure.

  3. Oswestry Disability index (ODI)

    10 questions assessing the functional impairment by the pain, using a 50 point scale, with 0 meaning no disability, and 50 meaning complete disability.

    Measured: 6 months post-procedure.

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted28 Feb 2024
  2. Study startAug 2027 (estimated)
  3. Primary completion30 Dec 2028 (estimated)
  4. Study completion30 Dec 2028 (estimated)

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Parallel groups
Model description
The subjects with bilateral low back pain will undergo radiofrequency ablation of the lumbar medial branch nerves using one approach (traditional) on one side and different approach (parasagittal) on the other side. One arm will use the traditional approach on the left and the parasagittal approach on the right. The other arm will use parasagittal approach on the left and the traditional approach on the right,
Masking
Double blind
Who is masked
Participant, Outcomes assessor
Enrolment
25 participants (estimated)
IDs, dates and publications
ClinicalTrials.gov ID
NCT06283628
Sponsor's protocol ID
STUDY00023737
Acronym
LMB-RFA
Status last verified
Oct 2025
First submitted
21 Feb 2024
Last updated
2 Nov 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
Individual data sharing
Yes: IPD data that underlie the results reported in this article, after deidentification (text, tables, figures)

Questions about this trial

What is this clinical trial studying?

A study testing Radiofrequency ablation of lumbar medial branch nerves. in people with Lumbar Spondylosis, run by Milton S. Hershey Medical Center at 1 site in United States.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 6 inclusion and 12 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: opening soon, as of the sponsor's last update on 2 Nov 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in United States. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

This study is still under way. Results are not available in the source record yet.

How can a doctor refer a patient or contact the research team?

Contact Nancy Ruth Jarbadan, BS (717-531-6135, njarbadan@pennstatehealth.psu.edu), or a site near the patient. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

The number of patients whose procedure was successful (gained 50% or more reduction in numeric rating pain (NRS) scores). (time frame: Baseline). The study lists 3 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 2 Nov 2026.

Free account

Log in to keep searching

You’ve used your 3 free searches. AzTrials is free: log in or create a free account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in